Bayer Cropscience Share Price

In terms of Regulation 47 of SEBI LODR Regulations 2015, please find attached herewith the newspaper advertisement for the unaudited financial results for the quarter ended June 30, 2026.

• BSE India
• 1 week ago

<h3><span style="font-size:16px;"><strong>Agrochemicals company Bayer Cropscience announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Revenue from Operations:</strong> For Q1FY27, revenue stood at Rs 18,350 million, representing a YoY decrease of 4.16% from Rs 19,146 million in Q1FY26, while showing a QoQ growth of 66.70% from Rs 11,008 million in Q4FY26.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Other Income:</strong> The company reported other income of Rs 889 million in Q1FY27, a significant YoY increase of 375.40% from Rs 187 million in Q1FY26 and a QoQ increase of 90.77% from Rs 466 million in Q4FY26. This includes a gain of Rs 639 million from the divestment of marketing rights for formulated products.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Total Income:</strong> Total income for Q1FY27 was Rs 19,239 million, a marginal YoY decline of 0.49% from Rs 19,333 million in Q1FY26, and a QoQ increase of 67.68% compared to Rs 11,474 million in Q4FY26.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Profit Before Tax (PBT):</strong> For the quarter ended Q1FY27, PBT stood at Rs 4,021 million, marking a YoY growth of 19.96% from Rs 3,352 million in Q1FY26 and a QoQ growth of 94.82% from Rs 2,064 million in Q4FY26.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Profit After Tax (Net Profit):</strong> Net profit in Q1FY27 reached Rs 3,216 million, increasing by 15.39% YoY from Rs 2,787 million in Q1FY26 and by 98.40% QoQ from Rs 1,621 million in Q4FY26.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Total Comprehensive Income:</strong> The company reported total comprehensive income of Rs 3,211 million in Q1FY27, a YoY increase of 15.38% from Rs 2,783 million in Q1FY26 and a QoQ increase of 108.64% from Rs 1,539 million in Q4FY26.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Earnings Per Share (EPS):</strong> Basic and diluted EPS for Q1FY27 was Rs 71.56, compared to Rs 62.01 in Q1FY26 and Rs 36.07 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1006311636="">Business Highlights</strong></p> <ul> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Segment Performance:</strong> The Company operates in a single reportable business segment, "Agri Care."</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Market Dynamics:</strong> The quarter reflected varied market dynamics across regions and product offerings. Corn seeds maintained momentum despite an overall decline in acreage, supported by hybrids and focused customer engagement.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Operational Benefits:</strong> Profitability was supported by improved gross margins driven by favorable pricing actions and a stronger product mix.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">One-time Income:</strong> The quarter's performance benefited from an income of Rs 639 million arising from the divestment of marketing rights for formulated products.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Working Capital:</strong> A key area of focus for the company remains improving working capital performance through inventory optimization and collections.</li> <li _ngcontent-ng-c1006311636=""><strong _ngcontent-ng-c1006311636="">Consolidation Note:</strong> The Company does not have any subsidiary, joint venture, or associate company; hence, it is not required to prepare consolidated financial results.</li> </ul> <p _ngcontent-ng-c1006311636=""><strong>Simon Wiebusch, Vice Chairman & Managing Director and CEO, Bayer CropScience, commented: </strong>“We delivered a resilient start to FY2026-27, with our performance reflecting disciplined execution amid challenging weather and evolving market conditions. The quarter reflected market dynamics across regions and product offerings. Corn seeds sustained momentum despite an overall decline in acreage, supported by the strength of our hybrids and focused customer engagement. As weather variability, including the potential impact of El Niño conditions, and evolving geopolitical developments continue to shape the operating environment, the company remains focused on proactive channel management, advancing our portfolio-led innovation, and creating sustainable value for farmers and stakeholders.”</p> <p _ngcontent-ng-c1006311636=""><strong>Vinit Jindal, Executive Director and Chief Financial Officer, Bayer CropScience, added: </strong>“Profit After Tax increased by 15% during the quarter, supported by improved gross margins driven by favorable pricing actions and a stronger product mix. The quarter also benefitted from an income of Rs 639 million arising from the divestment of marketing rights for formulated products. Other operating expenses were higher compared with the corresponding quarter of the previous year. Improving working capital performance through inventory optimization and collections remains a key area of focus.”</p> <p><a class="lb" href="/get-document/post/pdf/5767308/" target="_blank">Result PDF</a></p>

• Trendlyne
• 1 week 1 day ago

Bayer CropScience, the Indian unit of German crop science group Bayer AG, on Wednesday posted a 15.39 per cent rise in net profit to Rs 321.6 crore for the first quarter of FY27, supported by improved gross margins driven by favourable pricing actions and a stronger product mix. The company reported a net profit of Rs 278.7 crore a year earlier, according to a regulatory filing. Its total income declined marginally by 0.48 per cent to Rs 1,923.9 crore in the first quarter of 2026-27 from Rs 1,933.3 crore in the year-ago period. Expenses declined 5 per cent to Rs 1,521.8 crore against Rs 1,598.1 crore. Bayer CropScience Vice Chairman, Managing Director and CEO Simon Wiebusch said, "We delivered a resilient start to FY2026-27, with our performance reflecting disciplined execution amid challenging weather and evolving market conditions". The quarter reflected market dynamics across regions and product offerings. Corn seeds sustained momentum despite an overall decline in acreage, ..

• Business Standard
• 1 week 2 days ago